A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
12/1997
12/02/1997	US5693473 Linked breast and ovarian cancer susceptibility gene
12/02/1997	US5693470 Determining predisposition to hereditary non-polyposis colorectal cancer by testing cell samples for a mutant gene which affects expression of a protein indicator
11/1997
11/27/1997	WO1997044474A2 Viral particles which are masked or unmasked with respect to a cell receptor
11/27/1997	WO1997044466A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase
11/27/1997	WO1997044462A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/27/1997	WO1997044461A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
11/27/1997	WO1997044460A1 Modulators of tissue regeneration
11/27/1997	WO1997044454A2 Human phospholipase inhibitor
11/27/1997	WO1997044450A1 Regulation of gene expression
11/27/1997	WO1997044449A1 Promoters for swine complement inhibitors
11/27/1997	WO1997044440A1 Cell line
11/27/1997	WO1997044356A2 RET LIGAND (RetL) FOR STIMULATING NEURAL AND RENAL GROWTH
11/27/1997	WO1997044348A1 Ribozyme-mediated gene replacement
11/27/1997	WO1997044065A2 Device and method for encapsulated gene therapy
11/27/1997	WO1997044057A1 System and method for delivery of cytokines using encapsulated cytokine-secreting cells
11/27/1997	WO1997035976A3 Epidermal differentiation factor
11/27/1997	WO1997032572A3 Materials and methods for enhancing cellular internalization
11/27/1997	WO1997031111A3 A family of organic anion transporters, nucleic acids encoding them, cells comprising them and methods for using them
11/27/1997	DE19629938C1 Monoclonal antibodies specific for mutated E-Cadherin peptide sequences
11/27/1997	CA2255712A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase
11/27/1997	CA2255572A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus
11/27/1997	CA2253874A1 Viral particles which are masked or unmasked with respect to a cell receptor
11/27/1997	CA2253541A1 Human phospholipase inhibitor
11/27/1997	CA2252667A1 Device and method for encapsulated gene therapy
11/27/1997	CA2252665A1 System and method for delivery of cytokines using encapsulated cytokine-secreting cells
11/26/1997	EP0808905A2 Adenoviral vector for the transfer of human genes in vivo
11/26/1997	EP0808904A2 Interleukin-1 beta converting enzyme like apoptotic protease-6
11/26/1997	EP0808900A2 Polynucleotides and polypeptides associated with benign prostatic hypertrophy
11/26/1997	EP0808899A2 Human marco scavenger receptor (HMarcoSR)
11/26/1997	EP0808844A2 Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene and their use, combined with a differentiation inducer to cause apoptosis of leukemic blast cells
11/26/1997	EP0808630A1 Cancer control
11/26/1997	EP0808366A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF
11/26/1997	EP0808364A1 Human pancreatic cell lines: developments and uses
11/26/1997	EP0808324A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
11/26/1997	EP0808323A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF
11/26/1997	EP0808322A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF
11/26/1997	EP0808321A1 InK4c-p18 AND InK4D-p19, INHIBITORS OF CYCLIN-DEPEDENT KINASES CDK4 AND CDK6, AND USES THEREOF
11/26/1997	EP0808169A1 Programmed cell death genes and proteins
11/26/1997	EP0808104A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS
11/25/1997	US5691317 Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP dependent protein kinases for the treatment of cancer
11/25/1997	US5691306 Protein secretion
11/25/1997	US5691186 Filariid cysteine protease genes
11/25/1997	US5691177 Lymphocytes and genetic vectors for treatment of cancer or autoimmune diseases
11/25/1997	US5691175 Immortalized human fetal osteoblastic cells
11/25/1997	US5690929 Use of methioninase and chemotherapy agents in chemotherapy
11/25/1997	US5690927 Use of neuro-glial fetal cell lines for transplantation therapy
11/22/1997	CA2205078A1 Novel adenoviral vector for transferring human genes in vivo
11/20/1997	WO1997043404A2 Ribozyme variants with improved catalytic activity under low magnesium conditions
11/20/1997	WO1997043304A1 Novel compounds
11/20/1997	WO1997043303A1 Novel compounds
11/20/1997	WO1997042965A1 Amelioration of erectile dysfunction
11/20/1997	WO1997042820A1 Tristetraprolin
11/20/1997	WO1997042819A1 Cationic lipids for transfection of negatively charged or neutral molecules into living cells
11/20/1997	WO1997035994A3 Cytochrome p450 transducing retroviral vectors
11/20/1997	CA2289078A1 Cationic lipids for transfection of negatively charged or neutral molecules into living cells
11/19/1997	EP0807688A2 Nucleic acid construct for specific expression in vascular smooth muscle cells
11/19/1997	EP0807686A2 Interleukin-1 beta converting enzyme like apoptotic protease-7
11/19/1997	EP0807684A1 Human G-protein coupled receptor (HIBCD07)
11/19/1997	EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/19/1997	EP0807183A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
11/19/1997	EP0807181A1 NOVEL c-MPL LIGANDS
11/19/1997	EP0807176A2 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
11/19/1997	EP0807121A1 New pharmaceuticals for modulating hormone responsiveness
11/19/1997	EP0806967A1 Gene transfer for treating a connective tissue of a mammalian host
11/19/1997	EP0806966A1 Cationic copolymers of vinylamine and vinyl alcohol for the delivery of oligonucleotides
11/19/1997	EP0806965A1 Cd44 expression in smooth muscle cells
11/19/1997	EP0806964A1 Chemical compounds
11/19/1997	EP0731807A4 N-2 substituted purines
11/19/1997	CN1165537A Novel PKA-binding proteins and uses thereof
11/19/1997	CN1165147A Guanine nudeotide combined protein coupled receptor proteins, their production and use
11/18/1997	US5688915 Long term maintenance of lymphocytes in vitro
11/18/1997	US5688773 Method of selectively destroying neoplastic cells
11/18/1997	US5688692 Dna sequences and cell culture
11/18/1997	US5688677 Administering dna for treatment of cystic fibrosis with transmembrane conductance controllers
11/18/1997	US5688675 In vitro packaging of adeno-associated virus DNA
11/18/1997	US5688665 Binding to cyclin dependent kinases; controlling cell reproduction
11/18/1997	US5688651 Antiagglomerants, monoclonal antibodies, genetic engineered antibody antigens binding fragments and target polypeptides formed by denaturing target polypeptides, mixing, incubation and testing
11/18/1997	US5688637 Kits for detection of aids, amplification of strands of nucleic acid and hybridization in the presence of polymerases
11/18/1997	US5688511 Cellular protein TDP-43 and regulation of HIV-1 gene expression
11/18/1997	US5688499 Antagonism of endothelin actions
11/13/1997	WO1997042337A1 Gene expression in monocytes and macrophages
11/13/1997	WO1997042336A1 A long-term and high expression, single gene retroviral vector with applications to progenitor and mature haematopoietic cells
11/13/1997	WO1997042335A1 Polycistronic expression plasmid for tumor-rejection
11/13/1997	WO1997042330A1 Chain reaction cloning
11/13/1997	WO1997042323A1 Treatment of human cancers with an adenovirus vector containing an interferon consensus gene
11/13/1997	WO1997042224A1 Neurotactin and uses therefor
11/13/1997	WO1997042222A1 Methods and means for inhibition of cdk4 activity
11/13/1997	WO1997042219A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR
11/13/1997	WO1997042218A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
11/13/1997	WO1997042213A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
11/13/1997	WO1997042211A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor
11/13/1997	WO1997041892A1 Chimeric kanamycin resistance gene
11/13/1997	WO1997041834A1 Cationic virosomes as transfer system for genetic material
11/13/1997	WO1997041824A2 Antiangiogenic peptides derived from plasminogen
11/13/1997	WO1997037998A3 Neuropeptide y receptor y5 and nucleic acid sequence
11/13/1997	WO1997029195A3 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
11/13/1997	DE19620308A1 Vector for specific gene expression in vascular smooth muscle
11/13/1997	CA2253880A1 Chain reaction cloning
11/13/1997	CA2253864A1 Neurotactin and uses therefor
11/13/1997	CA2253561A1 Cationic virosomes as transfer system for genetic material

1 ... 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 ... 870